Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 3
1987 30
1988 25
1989 32
1990 23
1991 21
1992 19
1993 9
1994 10
1995 8
1996 5
1997 2
1998 4
1999 4
2000 11
2001 18
2002 10
2003 37
2004 58
2005 77
2006 104
2007 131
2008 170
2009 192
2010 219
2011 214
2012 263
2013 277
2014 270
2015 275
2016 264
2017 237
2018 229
2019 259
2020 260
2021 260
2022 259
2023 220
2024 102

Text availability

Article attribute

Article type

Publication date

Search Results

4,132 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cubilin (544 results)?
Daptomycin.
Heidary M, Khosravi AD, Khoshnood S, Nasiri MJ, Soleimani S, Goudarzi M. Heidary M, et al. J Antimicrob Chemother. 2018 Jan 1;73(1):1-11. doi: 10.1093/jac/dkx349. J Antimicrob Chemother. 2018. PMID: 29059358 Review.
Daptomycin has distinct mechanisms of action, disrupting multiple aspects of cell membrane function and inhibiting protein, DNA and RNA synthesis. Although daptomycin resistance in Gram-positive bacteria is uncommon, there are increasing reports of daptomycin …
Daptomycin has distinct mechanisms of action, disrupting multiple aspects of cell membrane function and inhibiting protein, DNA and R …
Daptomycin.
Tedesco KL, Rybak MJ. Tedesco KL, et al. Pharmacotherapy. 2004 Jan;24(1):41-57. doi: 10.1592/phco.24.1.41.34802. Pharmacotherapy. 2004. PMID: 14740787 Review.
Daptomycin, the first in a class of agents known as lipopeptides, is a novel antimicrobial agent used for the treatment of gram-positive infections. ...It has a safety profile similar to other agents commonly administered to treat gram-positive infections. Daptomycin …
Daptomycin, the first in a class of agents known as lipopeptides, is a novel antimicrobial agent used for the treatment of gram-posit …
Daptomycin.
Fenton C, Keating GM, Curran MP. Fenton C, et al. Drugs. 2004;64(4):445-55; discussion 457-8. doi: 10.2165/00003495-200464040-00009. Drugs. 2004. PMID: 14969579 Review.
Daptomycin is a lipopeptide antibacterial with rapid in vitro activity against Gram-positive cocci. ...In patients with cSSSIs, the adverse event profiles of daptomycin and vancomycin were similar. Creatine phosphokinase (CPK) levels increased in 2.8% of daptomyc …
Daptomycin is a lipopeptide antibacterial with rapid in vitro activity against Gram-positive cocci. ...In patients with cSSSIs, the a …
Daptomycin.
Kirkpatrick P, Raja A, LaBonte J, Lebbos J. Kirkpatrick P, et al. Nat Rev Drug Discov. 2003 Dec;2(12):943-4. doi: 10.1038/nrd1258. Nat Rev Drug Discov. 2003. PMID: 14756140 No abstract available.
Structure-Activity Relationships of Daptomycin Lipopeptides.
Karas JA, Carter GP, Howden BP, Turner AM, Paulin OKA, Swarbrick JD, Baker MA, Li J, Velkov T. Karas JA, et al. J Med Chem. 2020 Nov 25;63(22):13266-13290. doi: 10.1021/acs.jmedchem.0c00780. Epub 2020 Aug 6. J Med Chem. 2020. PMID: 32687352 Review.
Daptomycin is a calcium-dependent cyclic lipodepsipeptide derived from the soil saprotroph Streptomyces roseosporus, and its antibiotic properties make it a key agent for treatment of drug-resistant Gram-positive infections. ...
Daptomycin is a calcium-dependent cyclic lipodepsipeptide derived from the soil saprotroph Streptomyces roseosporus, and its antibiot …
Cubicin Outcomes Registry and Experience (CORE) methodology.
Rolston KV, Segreti J, Lamp KC, Friedrich LV. Rolston KV, et al. Am J Med. 2007 Oct;120(10 Suppl 1):S4-5. doi: 10.1016/j.amjmed.2007.07.008. Am J Med. 2007. PMID: 17904949
The Cubicin Outcomes Registry and Experience (CORE), was designed to retrospectively collect the real-world postmarking experience of patients who received daptomycin. ...Data on 1,160 patients from November 2003 until December 2004 were collected on demographics, i …
The Cubicin Outcomes Registry and Experience (CORE), was designed to retrospectively collect the real-world postmarking experience of …
Daptomycin.
Enoch DA, Bygott JM, Daly ML, Karas JA. Enoch DA, et al. J Infect. 2007 Sep;55(3):205-13. doi: 10.1016/j.jinf.2007.05.180. Epub 2007 Jul 16. J Infect. 2007. PMID: 17629567 Review.
There has been a steady rise in the prevalence of resistant Gram-positive pathogens and concerns about the clinical effectiveness of glycopeptides in treating infections due to Staphylococcus aureus. Daptomycin is a novel lipopeptide antimicrobial agent with activity again …
There has been a steady rise in the prevalence of resistant Gram-positive pathogens and concerns about the clinical effectiveness of glycope …
The action mechanism of daptomycin.
Taylor SD, Palmer M. Taylor SD, et al. Bioorg Med Chem. 2016 Dec 15;24(24):6253-6268. doi: 10.1016/j.bmc.2016.05.052. Epub 2016 May 28. Bioorg Med Chem. 2016. PMID: 27288182 Review.
Instead, the best characterized effect of daptomycin is the permeabilization and depolarization of the bacterial cell membrane. ...Daptomycin's complex structure and biosynthesis have hampered the analysis of its structure activity relationships. ...
Instead, the best characterized effect of daptomycin is the permeabilization and depolarization of the bacterial cell membrane. ... …
Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF, Friedrich LV, Yankelev S, Lamp KC. Mohr JF, et al. Int J Antimicrob Agents. 2009 Jun;33(6):543-8. doi: 10.1016/j.ijantimicag.2008.12.007. Epub 2009 Feb 6. Int J Antimicrob Agents. 2009. PMID: 19201165
Studies in vitro as well as animal and case studies suggest that daptomycin may be effective in enterococcal infections. Patients with positive blood cultures for enterococci in the Cubicin((R)) Outcomes Registry and Experience (CORE) 2005-2006 were identified. ...A …
Studies in vitro as well as animal and case studies suggest that daptomycin may be effective in enterococcal infections. Patients wit …
Safety of daptomycin in patients completing more than 14 days of therapy: results from the Cubicin Outcomes Registry and experience.
Rege S, Mohr J, Lamp KC, Yoon M, Lindfield KC. Rege S, et al. Int J Antimicrob Agents. 2013 May;41(5):421-5. doi: 10.1016/j.ijantimicag.2012.12.008. Epub 2013 Feb 5. Int J Antimicrob Agents. 2013. PMID: 23394685
Patients with complicated infections may receive daptomycin for extended periods. This retrospective analysis was conducted to describe the safety profile of daptomycin in patients completing >14 days of therapy. In the Cubicin() Outcomes Registry and Expe …
Patients with complicated infections may receive daptomycin for extended periods. This retrospective analysis was conducted to descri …
4,132 results